3 Stocks Under $50 We Keep Off Our Radar The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ Invesco's biotech fund surged 56.4% in one year, while Fidelity's broader healthcare portfolio offers lower costs and steadier returns.
Invesco KBW Bank ETF Wins on Yield and 1-Year Return. Is It a Better Financials Fund Than IYF? KBWB concentrates on 26 banking stocks with higher yield, while IYF diversifies across more than 140 financial firms with lower volatility.
Stock Market Today, Sept. 1: Stocks Slide and Oil Surges Amid U.S.-Iran Tension On Sept. 1, 2026, rising crude and Treasury yields pressured equities across nearly every sector, with tech stocks bearing the brunt of the selloff.
Prediction: If a September Sell-Off Hits Speculative AI Stocks, Quantum Computing Falls First Quantum computing stocks may drop dramatically if investors decide they've been paying too much for hoped-for future growth.
QUICK SPARK: Invesco’s RSP Hits $100 Billion as Equal-Weight ETFs Gain Ground Invesco’s RSP ETF hits $100 billion in AUM as investors seek equal-weight exposure to reduce reliance on mega-cap S&P 500 stocks.
This Unstoppable ETF Could Turn $100 per Month Into $40,000 With Next to No Effort on Your Part. Here's How. Committed set-it-and-forget-it investors would do well to consider the long-term potential of the Invesco NASDAQ 100 ETF.
If You'd Invested $1,000 in QQQ 20 Years Ago, Here's What You'd Have Today Your investment would have grown substantially, but only if you exercised discipline and patience.
Better Growth Stock ETF: Vanguard's Large-Cap VUG vs. Invesco's Small-Cap RZG VUG delivered 80% higher five-year returns despite a 10x higher expense ratio, but RZG surged 26.9% over the past year.
What I Learned From Investing Through 3 Big Stock Market Crashes The stock market has recovered from the biggest crashes. Crises end, but the world keeps going.
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.
If I Could Invest in Just 1 ETF in 2026, Here's Where I'd Buy Invesco's NASDAQ 100 ETF is a great growth play for long-term investors.
Own VOO? Here's the Problem With Adding This Popular Growth ETF. Pairing VOO with QQQM gives you two top performers. But is it the best idea from a portfolio construction standpoint?
3 Cash-Producing Stocks That Fall Short While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole Call option volume in the Invesco DB U.S. Dollar Index Bearish Fund (UDN) surged roughly 1,144%, as traders weigh the Treasury's expanded bond buybacks against the Fed's Jackson Hole policy stance.
The Ultimate Growth ETF to Buy With $1,000 Right Now The Invesco Nasdaq 100 ETF has proven to be a consistent, reliable market outperformer.
How to Invest for an AI Boom, AI Bust, or...Both: These ETFs Can Help. It feels like we're reaching a moment of peak doubt about the AI boom, so investors have big choices to make.
The S&P 500's Biggest Stocks Keep Getting Bigger. Here's the ETF I'd Buy to Diversify The S&P 500 is historically top-heavy. Keep your large-cap exposure, but own the S&P 500 differently.
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? Here's how Invesco's concentrated pharma play compares to Fidelity's diversified approach to healthcare stocks.
